OBJECTIVES: Irrational use of antibiotics is always the concern of health care system because of its negative effects. This study aimed to evaluate antibiotic use in a state hospital in Hue, Vietnam with its cost, using the ATC/DDD index. METHODS: This study was performed as a point prevalence study in a 180-bed state hospital. Data of using antibiotics on 2016 were collected. Antibiotic use and cost analysis were evaluated using the ATC/DDD index, which is also suggested by the WHO to be used in similar studies. RESULTS: Antibiotics accounted for 9.71% of products volume and 21.85% of total drug expense. Of 9 antibiotic groups used, value of beta-lactam group was the highest (84.5%). In beta-lactam group, cephalosporins occupied the highest value (89.35%), particularly the third generation ones (78,95%) . Cefadroxil is the oral antibiotic consumed most widely (16, 431 DDD) with the average cost per DDD of 0.15 USD. Ceftazidim was the injectable antibiotics used more than any others (75.91 DDD/1,000 bed-days and the cost per DDD of 6.90 USD). Cefotaxime and ceftriaxone are the second and third injectable antibiotic most commonly used, respectively. Although the average cost per DDD of cefotaxime is twice more than that of ceftriaxone (3.51 USD versus 1.39 USD), cefotaxime was used at higher amount (12.80 DDD/1,000 bed-days versus 2.76 DDD/1,000 bed-days). CONCLUSIONS: Antibiotics, especially cephalosporin, occupied the highest proportion of the total drug expense. The hospital gave priority to the use of first-line oral antibiotics which often had the lower cost per DDD. However, injectable antibiotics with higher cost per DDD were still used commonly. Malla B Gandaki Medical College, Pokhara Lekhnath, Nepal OBJECTIVES: The current means to control the bacterial infections rely heavily on the use of antibiotics, but irrational use of antibiotics without prescription, poor sanitation conditions, use of antibiotics agents in agriculture, and small health care budgets in the developing countries like Nepal are some of the causes of the bacterial resistance. Therefore, this research aims to evaluate knowledge, perception and attitude of students regarding the antibiotics use and resistance in Nepal. METHODS: An institution based descriptive cross-sectional study design was conducted from 11 June to 20 December 2017 to assess the knowledge, perception and attitude of first and second year students regarding the antibiotics use and resistance in Nepal. RESULTS: Out of 170 students 91 were male and 79 were female students. Majority of students (98.9%) used antibiotics to treat bacterial infection (P< 0.001). However, 59.6% students misunderstand that antibiotics are over the counter drugs and 36.9% students misunderstand that antibiotics can also be used to treat viral infections like common cold due to influenza, acute viral bronchitis and viral pharyngitis (P< 0.05). 97.3% students are aware about the irrational use of antibiotics and the harm caused by it (P< 0.001). In spite of strong knowledge in rational use of antibiotics, majority of them stop taking antibiotics when they feel better after bacterial infection and have left over antibiotics at home (P< 0.05). Moreover, 52.1% students depended mainly on text book for the sources of information. CONCLUSIONS: In this study we concluded that to address the growing problem of antibiotic resistant in Nepal future doctors, nurses and other health care workers must have better knowledge, attitude and well prepared to use antibiotics more sparingly and appropriately.
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PIN35 ANTIBIOTIC USE IN A CLINICAL DEPARTMENT OF A UNIVERSITY HOSPITAL IN VIETNAM
Luong MN 1 , Tram NB 1 , Truong VT 1 , Vo TH 2 1 Hue University of Medicine and Pharmacy, Hue University, Hue, Viet Nam, 2 Hue University Hospital, Hue, Viet Nam OBJECTIVES: The objective of the study was to assess antibiotic use in a clinical department of a university hospital. METHODS: A cross-sectional descriptive study was conducted at the Department of Internal Medicine -Endocrinology in the 600bed Hue University Hospital. Data was collected from medical records of inpatients that were prescribed at least one antibiotic during hospital stay and were hospitalised in August 2017. The costs of antibiotics were retrieved from administrative data in pharmacy department. RESULTS: Of 100 patients collected, 93% of patients used antibiotics had signs and/or symptoms of infections. The average number of antibiotics prescribed in patients was 2.1 ± 0.3. Of 20 antibiotics used, beta-lactams were used most commonly (89% patients), followed by quinolones and imidazole groups (43% and 30%, respectively). About a half of patients used monotherapy. While 88% of patients were prescribed injectbale antibiotics 33% took oral antibiotics. The proportion of patients' prescriptions had drug interactions between antibiotics and other drugs was 43%, of which the majority were mild-to-moderate interactions. Cost analysis found that costs of injectable antibiotics accounted for 99% of the total cost of antibiotics. CONCLUSIONS: The majority of patients were used injectable antibiotics with a high cost. Implementation of antibiotic stewardship interventions are needed to improve optimal antibiotic use.
PIN37 DRUG UTILISATION EVALUATION IN DIABETIC FOOT SURGERY
Koshy SA 1 , Krishna Murthy M 2 Han R, Zhou J Aix-Marseille University, Marseille, France OBJECTIVES: Our objectives were to investigate the humanistic and economic burden of HCV. METHODS: Systematic reviews of HCV-related humanistic and economic burden were identified through Medline and Embase. HRQoL, resource use, and cost of HCV patients were extracted. RESULTS: Of the 1218 studies identified, 8 systematic reviews were included, with 7 reviews considering humanistic burden and 1 considering economic burden. For humanistic burden, 5 reviews reported quantitative results. Three reviews reported utility value including 23 studies and covering 9,221 persons from China, Canada, United States, Germany, United Kingdom and Korea. Utility value was mostly elicited with indirect measurement (n= 20) using SF-36 (0.62-0.89, n= 18), EQ-5D (0.57-0.79, n= 2), HUI2 (0.71-0.84, n= 1) and HUI3 (0.69-0.74, n= 1)). Utility value was also elicited by direct method in 3 studies using visual analogue scale (0.57-0.92, n= 3), standard gambling (0.60-0.83, n= 2) and time trade-off (0.72-0.90, n= 1). The disutility for mild chronic hepatitis C with values ranged from -0.03 to -0.16 by SF-6D and from -0.08 to -0.26 by EQ-5D, and for decompensated cirrhosis ranged from -0.11 to -0.22 by SF-36 and from -0.14 to -0.33 by EQ-5D.Two reviews including 15 studies reported mean differences between HCV and healthy controls across the 8 SF-36 scales. The largest impact of HCV was in the role physical scale (-15.8 points), followed by the role emotional scale (-13.0) and the general health scale (-12.6 ). Qualitative HRQol was reported in 2 reviews including 46 studies. HCV was found associated with poorer HRQoL and health state due to physical symptoms and stigmatization. The review for economic burden reported absenteeism including 11 studies. Compared with healthy controls, HCV patients had higher rates of absenteeism (3.0-5.5% VS. 4.9-8.6%), presenteeism (13.5-21.0% VS. 16.7-27.1%), and overall work impairment (15.0-18.3% VS. 19.4-30.5%). CONCLUSIONS: HCV patients have a low HRQoL and substantial work impairment. However, information on economic burden for HCV remains limited.
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PIN31 ECONOMIC IMPACT OF DELAYED ACCESS TO SOFOSBUVIR-BASED REGIMEN UNDER THE THAI UNIVERSAL HEALTH COVERAGE (UHC)
Sirajiranuwat P, Sathittanapat S, Bunjongrod S, Taychakhoonavudh S Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand OBJECTIVES: In 2015, local data showed that sofosbuvir is a cost-saving intervention compared to peg-interferon and ribavirin (PR). Due to its high budget impact, sofosbuvir was just recently introduced as a standard treatment under the Thai UHC in February 2018. This study was conducted to assess the economic impact of delayed access to sofosbuvir-based regimen from a health insurance payer perspective. METHODS: A model-based economic evaluation approach was used to estimate the economic impact of delayed access to sofosbuvir-based regimen (scenario 1) compare to introduction of a sofosbuvir-based regimen in 2015 (scenario 2). Costs were estimated as direct medical costs including drug costs for HCV infection treatment and direct medical costs for HCV-related complications. We considered three hypothetical cohorts of patients with chronic HCV infection who could have accessed to sofosbuvir and followed them in the model for 30 years. All costs were discounted at 3%. RESULTS: In scenario 1, PR was a drug of choice and total costs of PR would be $134,450,156. If sofosbuvir was adopted in 2015, drug costs for the treatment of HCV would be $22,825,343 higher or a total of $157,275,500. Direct medical costs for the treatment of HCV-related complications are however, higher in scenario 1 compare to scenario 2 ($17,093,721,504 vs $16,985,604,114, respectively) . The total savings if sofosbuvir was adopted in 2015 would be $85,292,046. Our finding suggests that adopting sofosbuvir in 2015 would still be a cost-saving alternative if the price is cut at least by 40%. CONCLUSIONS: When evidences show that Intervention is cost-saving, including the drug in the health insurance benefit schemes at the earliest provide higher benefit than prolonged access. Country can use other policy instruments to manage budget impact for example, risk sharing agreement.
PIN32 ECONOMIC IMPACT OF VACCINE PROCUREMENT STRATEGIES: CASE STUDY OF JAPANESE ENCEPHALITIS VACCINE
Kulthanachairojana N 1 , Taychakhoonavudh S 2 1 Faculty of Pharmaceutical Science Chulalongkorn University, Bangkok, Thailand, 2 Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand OBJECTIVES: National Immunization Programs (NIP) are currently challenged to the security of supply of vaccines especially basic vaccines in which producers moved away from producing. Our aim is to estimate the economic impact of different procurement strategies for Live attenuated-Japanese encephalitis (LAJE) vaccine form a societal perspective. METHODS: The decision-analytical model was developed to evaluate the impact of different procurement strategies includes current purchasing method (year to year procurement), multi-year tender, regional pooled procurement and procurement from the local manufacturers. Economic impact was estimated by including the procurement cost of LAJE and the probabilities and consequences of outbreak if vaccine shortage. Input parameters were obtained from published literature and expert opinion including probabilities of shortage. RESULTS: Vaccine procurement costs were based on the negotiating power of the government with the cheapest procurement costs of US$ 187.98 million (local manufacturers) followed by US$ 216.45, US$ 232.28, US$ 262.70 million for regional pooled procurement, multi-year tender and current purchasing, respectively. Local manufacturers were assumed the most secured source of vaccine and as a consequence the lowest chance of JE infection with the JE treatment costs of US$ 0.99, 1.22, 1.22 and 1.31 million for purchasing from local manufacturers, multi-year tender, pooled procurement and current purchasing, respectively. Switching from current purchasing strategy to purchasing from local manufacturers would save the country's budget by US$ 75.10 million in 30 years. The results show the same trend with multi-year tender and pooled procurement options. CONCLUSIONS: The results support economic rationale for purchasing the vaccines from local manufacturers especially if vaccine
